Hadron therapy, PXI team up against tumors
Hadron therapy for cancer treatment continues to move forward at the CNAO's synchrotron lab in Italy, where National Instruments' LabVIEW software and PXI hardware are playing an integral role in synchrotron operations.
From National Instruments: Non-invasive cancer treatments like chemotherapy and radiation can have a crippling effect on the human body, resulting in severe damage to both healthy and cancerous tumor cells. Fortunately, it's possible to advance a unique, more accurate form of cancer treatment known as hadron or proton therapy, where accelerated particle beams such as protons or carbon ions can precisely target deep-seated cancer cells. Recent advances in this technology have accelerated research on the technique from the Italian National Center for Oncological Hadron therapy (CNAO), which estimates that more than 3,000 new patients per year will be treated with hadron therapy and this number can be expected to steadily increase.
More on this topic at EDN